Noninvasive detection of any-stage cancer using free glycosaminoglycans

Cancer mortality is exacerbated by late-stage diagnosis. Liquid biopsies based on genomic biomarkers can noninvasively diagnose cancers. However, validation studies have reported ~10% sensitivity to detect stage I cancer in a screening population and specific types, such as brain or genitourinary tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bratulic, Sinisa, Limeta, Angelo, Dabestani, Saeed, Birgisson, Helgi, Enblad, Gunilla, Stålberg, Karin, Hesselager, Göran, Häggman, Michael, Höglund, Martin, Simonson, Oscar E., Stålberg, Peter, Lindman, Henrik, Bång-Rudenstam, Anna, Ekstrand, Matias, Kumar, Gunjan, Cavarretta, Ilaria, Alfano, Massimo, Pellegrino, Francesco, Mandel-Clausen, Thomas, Salanti, Ali, Maccari, Francesca, Galeotti, Fabio, Volpi, Nicola, Daugaard, Mads, Belting, Mattias, Lundstam, Sven, Stierner, Ulrika, Nyman, Jan, Bergman, Bengt, Edqvist, Per-Henrik, Levin, Max, Salonia, Andrea, Kjölhede, Henrik, Jonasch, Eric, Nielsen, Jens, Gatto, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897435/
https://www.ncbi.nlm.nih.gov/pubmed/36469776
http://dx.doi.org/10.1073/pnas.2115328119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897435/
https://www.ncbi.nlm.nih.gov/pubmed/36469776
http://dx.doi.org/10.1073/pnas.2115328119

Ejemplares similares